Schedule 13D ownership disclosure

EIDOS THERAPEUTICS INC

Security class unavailable · CUSIP: 28249H104

Event date: 2020-10-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,798,339
Percent of class
4.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-113116
Form type
SC 13D/A
Filer
Eidos Therapeutics, Inc.
CIK
CIK 1731831
Filed
Oct 07, 2020
Reporting period
Oct 05, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub